Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
Emanuele F. Osimo, Katherine Beck, Tiago Reis Marques, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 4, pp. 549-561
Open Access | Times Cited: 215

Showing 1-25 of 215 citing articles:

Schizophrenia—An Overview
Robert A. McCutcheon, Tiago Reis Marques, Oliver Howes
JAMA Psychiatry (2019) Vol. 77, Iss. 2, pp. 201-201
Closed Access | Times Cited: 1011
Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen Kaar, Sridhar Natesan, Robert A. McCutcheon, et al.
Neuropharmacology (2019) Vol. 172, pp. 107704-107704
Closed Access | Times Cited: 291
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi, Els F. Halff, Thomas Whitehurst, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 189
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis
Oliver Howes, Thomas Whitehurst, Ekaterina Shatalina, et al.
World Psychiatry (2021) Vol. 20, Iss. 1, pp. 75-95
Open Access | Times Cited: 162
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver Howes, Ekaterina Shatalina
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 501-513
Open Access | Times Cited: 160
The synaptic hypothesis of schizophrenia version III: a master mechanism
Oliver Howes, Ellis Chika Onwordi
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1843-1856
Open Access | Times Cited: 96
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
Oliver Howes, Connor Cummings, George E. Chapman, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 151-167
Open Access | Times Cited: 83
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
Nikhilesh Anand, Vasavi Rakesh Gorantla, Saravana Babu Chidambaram
Cells (2022) Vol. 12, Iss. 1, pp. 54-54
Open Access | Times Cited: 80
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 64
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 58
Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies
Amber Berdenis van Berlekom, Cita Hanif Muflihah, Gijsje J. L. Snijders, et al.
Schizophrenia Bulletin (2019)
Open Access | Times Cited: 130
Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Biomarker Insights (2020) Vol. 15, pp. 117727192095031-117727192095031
Open Access | Times Cited: 109
Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment
David Mongan, Matthew Ramesar, Melanie Föcking, et al.
Early Intervention in Psychiatry (2019) Vol. 14, Iss. 4, pp. 385-397
Open Access | Times Cited: 100
Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
Tertia D. Purves-Tyson, Kate Robinson, Amelia M. Brown, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80
Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders
Zhonghua Hu, Xiao Xiao, Zhuohua Zhang, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 10, pp. 1400-1414
Closed Access | Times Cited: 79
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia
Eduard Parellada, Patricia Gassó
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 78
In vivo evidence of lower synaptic vesicle density in schizophrenia
Rajiv Radhakrishnan, Patrick D. Skosnik, Mohini Ranganathan, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7690-7698
Closed Access | Times Cited: 76
Schizophrenia Genomics: Convergence on Synaptic Development, Adult Synaptic Plasticity, or Both?
Jérémy Hall, Nicholas J. Bray
Biological Psychiatry (2021) Vol. 91, Iss. 8, pp. 709-717
Open Access | Times Cited: 64
The dual hit hypothesis of schizophrenia: Evidence from animal models
Cyprien G.J. Guerrin, Janine Doorduin, Iris E. Sommer, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 1150-1168
Open Access | Times Cited: 58
Emerging evidence for astrocyte dysfunction in schizophrenia
Eva Cristina de Oliveira Figueiredo, Corrado Calì, Francesco Petrelli, et al.
Glia (2022) Vol. 70, Iss. 9, pp. 1585-1604
Open Access | Times Cited: 53
Imaging Synaptic Density: The Next Holy Grail of Neuroscience?
Maria Elisa Serrano Navacerrada, Eugene Kim, Marija M. Petrinovic, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 46
Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models
David Wegrzyn, Georg Juckel, Andréas Faissner
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5482-5482
Open Access | Times Cited: 42
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation
Gilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 44-58
Closed Access | Times Cited: 39
Network-Based Spreading of Gray Matter Changes Across Different Stages of Psychosis
Sidhant Chopra, Ashlea Segal, Stuart Oldham, et al.
JAMA Psychiatry (2023) Vol. 80, Iss. 12, pp. 1246-1246
Open Access | Times Cited: 32
Schizophrenia genomics: genetic complexity and functional insights
Patrick F. Sullivan, Shuyang Yao, Jens Hjerling‐Leffler
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 9, pp. 611-624
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top